Résumé
2 patients acromégales souffrant d’algies vasculaires de la face (AVF) sont soulagés par l’injection d’ocréotide (somatostatine de synthèse). Cette association d’AVF, d’acromégalie et de sensibilité à la somatostatine n’est pas publiée et conduit à envisager de nouvelles hypothèses pathogéniques pour l’AVF. Nos patients avaient bénéficié d’une exérèse complète d’un macro-adénome à GH qui n’est donc pas responsable de la symptomatologie par un mécanisme compressif. L’association syndromique AVF et acromégalie est probablement fortuite mais l’effet bénéfique de la somatostatine sur les crises d’AVF pose plusieurs questions: est ce un rôle antalgique général du peptide qui est bien documenté, est ce l’intervention sur le sommeil ou est ce l’effet vasculotrope authentique de la somatostatine...? Notre hypothèse est que la somatostatine jouerait sur les processus vasculaires et inflammatoires présents au niveau du sinus caverneux au cours des crises d’AVF. L’effet pourrait être comparable à celui des médicaments à impact sérotoninergique, tant dans l’effet bénéfique sur la crise que dans la dépendance qui se développe au long cours chez les deux patientes.
Summary
We describe 2 patients diagnosed with acromegaly presented cluster headache (CH) that responded to subcutaneous injections of octreotide (somatostatin synthetic analogue). That association of CH with acromegaly and the fact that CH improves with somatostatin is unpublished. This work has led us to find explanations according to the semiology of these patients and to the literature of the somatostatin effects. Our patients had a complete tumorectomy of their macro adenoma, therefore we considere that it was not the cause of their CH. Other hypothesis could be proposed: First, somatostatin itself has an analgesic effect that has been already described but not in CH. A second hypothesis is that somatostatin would be a neuromediator that takes place in sleep regulation equally involved in pathogenis of CH. The third hypothesis is vascular and inflammatory; these processes occur in the cavernous sinus during cluster headache attacks according to the trigemino-vascular hypothesis. Treatments for cluster headache, especialy the triptan act on that inflammatory process of carotid as the somatostatin which possess a vascular tropism. That interpretation of somatostatin may explain the improvement of CH in our cases with occurrence of dependance and addiction.
Abbreviations
- AVF:
-
Algie Vasculaire de la Face
- IRM:
-
Imagerie par Résonance Magnétique
- SST:
-
Somatostatine
- GH:
-
Growth Hormone
- IGF:
-
Insuline Like Growth Factor
- PRL:
-
Prolactine
- CGRP:
-
Calcitonin Gene Related Peptide
- SRIF:
-
Somatotrophin Release Inhibiting Factor
- REM sleep:
-
Rapid Eyes Movement Sleep
- SAS:
-
Syndrome d’Apnée du Sommeil
Bibliographie
Milos P., Havelius U. andHindfeld B.: Cluster Headache in a patient with a pituitary adenoma. With a review of the literature.Headache 36, 184–188, 1996.
Greve E. andMai J.: Cluster headache-like headaches: a symptomatic feature? A report of three patients with intracranial pathologic findings.Cephalalgia 8 (2), 79–82, 1988.
Tfelt-Hansen P., Paulson O.B. andKrabbe A.A.: Invasive adenoma of the pituitary gland and chronic migrainous neuralgia. A rare coincidence or a causal relationship?Cephalalgia 2 (1), 25–28, 1982.
Beaulieu E.E. andKelly P.: Growth hormone and prolactin. In hormones from molecule to disease. Ed. Hermann, 191–223, 1990.
Idelman S.: Endocrinologie générale. In: endocrinologie: fondements physiologiques. Ed. collection Grenoble science, 22–64.
Perlemuter G.: Acromégalie. In: endocrinologie: diabétologie, nutrition. Ed Medline, 131–146, 1997.
May A., Ashburner J., Buchel C., McGonigle D.J., Friston K.J., Frackowiak R.S. andGoadsby P.J.: Correlation between structural and functional changes in brain in an idiopathic headache syndrome.Nat. Med. 5 (7), 836–838, 1999.
May A. andGoadsby P.J.: Hypothalamic involvement and activation in cluster headache.Curr. Pain Headache Rep. 5 (1), 60–66, 2001.
May A., Bahra A., Buchel C., Frackowiak R.S. andGoadsby P.J.: Hypothalamic activation in cluster headache attacks.Lancet 25, 352 (9124), 275-278, 1998.
Moore R.Y.: Circadian rhythms: basic neurobiology and clinical applications.Annu. Rev. Med. 48, 253–266, 1997.
Hardebo J.E.: How cluster headache is explained as an intracavernous inflammatory process lesioning sympathetic fibber.Headache 34 (3), 125–131, 1994.
Buzzi M.G. andMoskowitz M.A.: The trigemino-vascular system and migraine.Pathol. Biol. (Paris) 40 (4), 313–317, 1992.
Goadsby P.J., Edvinsson L. andEkman R.: Vasoactive peptide release in the cerebral circulation of human during migraine headache.Ann. Neurol. 28, 183–187, 1990.
Waeber C.: Cerebral dura mater and cephalalgia.Cephalalgia 18 (4), 171, 1998.
Drummond P.D. andLance J.W.: Pathological sweating and flushing accompanying the trigeminal lachrymal reflex in patients with cluster headache and in patients with a confirmed site of cervical sympathetic deficit. Evidence for parasympathetic cross-innervation.Brain.115 (5), 1429–1445, 1992.
Mione M.C., Cavanagh J.F., Kirkpatrick K.A. andBurnstock G.: Plasticity in expression of calcitonin gene-related peptide and substance P immunoreactivity in ganglia and fibres following guanethidine and/or capsaicin denervation.Cell Tissue Res. 268 (3), 491–504, 1992.
Williams R., Bienenstock J. andStead R.: Mast Cell: The neuroimmune connectionin: Marone G (ed): Human basophils and mast cells: Biological Aspect;Chem Immuol.Basel, Krager, 61, 208–235, 1995.
Ottosson A. andEdvinsson L.: Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide.Cephalalgia 17 (3), 166–174, 1997.
Reynier-Rebuffel A.M., Mathiau P., Callebert J., Dimitriadou V., Farjaudon N., Kacem K., Launay J.M., Seylaz J. andAbineau P.: Substance P, calcitonin gene-related peptide, and capsaicin release serotonin from cerebrovascular mast cells.Am. J. Physiol. 267 (5 Pt 2), R1421–9, 1994.
Reynier-Rebuffel A.M., Callebert J., Dimitriadou V., Mathiau P., Launay J.M., Seylaz J. andAubineau P.: Carbachol induces granular cell exocytosis and serotonin release in rabbit cerebral arteries.Am. J. Physiol. 262 (1 Pt 2), R105–11, 1992.
Keller J.T., Dimlich R.V., Zuccarello M., Lanker L., Strauss T.A. andFritts M.J.: Influence of the sympathetic nervous system as well as trigeminal sensory fibres on rat dural mast cells.Cephalalgia 11 (5), 215–221, 1991.
Christian E.P., Undem B.J. andWeinreich D.: Endogenous histamine excites neurones in the guinea-pig superior cervical ganglion in vitro.J. Physiol. 409, 297–312, 1989.
Dexter J.D. andWeitzman E.D.: The relationship of nocturnal headaches to sleep stage patterns.Neurology 20 (5), 513–518, 1970.
Manzoni G.C., Terzano M.G., Moretti G. andCocchi M.: Clinical observations on 76 cluster headache cases.Eur. Neurol. 20 (2), 88–94, 1981.
Buckle P., Kerr P. andKryger M.: Nocturnal cluster headache associated with sleep apnea.A case report.Sleep. 16 (5), 487–489, 1993.
Nath S.T., Hall J.M., Sharma N. andChervin R.D.: Relationship of noctural occurrence of cluster headaches to symptoms of obstructive sleep apnea.Neurology 50 (suppl. 4), 274–275, 1998.
Paiva T., Batista A., Martins P. andMartins A.: The relationship between headaches and sleep disturbances.Headache 35, 590–596, 1995.
Chervin R.D., Zallek S.N., Lin X., Hall J.M., Sharma N. andHedger K.M.: Sleep disordered breathing in patients with cluster headache.Neurology 27, 54 (12), 2302–2306, 2000.
Lüdemann P., Frese A., Happe S. andEvers S.: Sleep disordered breathing in patients with cluster headache.Neurology 10, 56 (7), 984, 2001.
Chazot G., Claustrat B., Brun J., Jordan D., Sassolas G. andSchott B.: A chronobiological study of melatonin, cortisol growth hormone and prolactin secretion in cluster headache.Cephalalgia 4 (4), 213–220, 1984.
Waldenlind E., Gustafsson S.A., Ekbom K. andWeeterberg L.: Circadian secretion of cortisol and melatonin in cluster headache during active cluster periods and remission.J. Neurol. Neurosurg. Psychiatry 50 (2), 207–213, 1987.
Leone M., D’Amico D., Moschiano F., Fraschini F. andBussone G.: Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups.Cephalalgia 16 (7), 494–496, 1996.
Basbaum A.I. andFields H.L.: Endogenous pain control mechanisms: review and hypothesis.Ann. Neurol. 4 (5), 451–462, 1978.
Krisch B.: Somatostatin-immunoreactive fibber projections into the brain stem and the spinal cord of the rat.Cell. Tissue Res. 217 (3), 531–552, 1981.
Hoyer D., Bell G.I., Berelowitz M., Epelbaum J., Feniuk W., Humphrey P.P., O’Carroll A.M., Patel Y.C., Schonbrunn A., Taylor J.E. et al.: Classification and nomenclature of somatostatin receptors.Trends Pharmacol. Sci. 16 (3), 86–88, 1995.
Meriney S.D., Gray D.B. andPilar G.R.: Somatostatin-induced inhibition of neuronal Ca2+ current modulated by cGMP-dependent protein kinase.Nature 26, 369 (6478), 336–339, 1994.
Evans C.J., Keith D.E. Jr,Morrison H., Magendzo K. andEdwards R.H.: Cloning of a delta opioid receptor by functional expression.Science 18, 258 (5090), 1952–1955, 1992.
Chieng B., Connor M. andChristie M.J.: The mu-opioid receptor antagonistd-Phe-Cys-Tyr-d-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but notd-Phe-Cys-Tyr-d-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.Mol. Pharmacol. 50 (3), 650–655, 1996.
Sandkülher J., Fu Q.G. andHelmchem C.: Spinal somatostatin surfusion in vivo affects activity of cat nociceptive dorsal horn neuron: Comparison with spinal morphine.Neuroscience 34, 565–576, 1990.
Chrubasik J., Bonath K., Cramer H., Rissler K. andWünsch E.: Permeability of epidural somatostatin and morphine into the intrathecal space of dogs.Regul. Pept. 13, 119–124, 1986.
Chrubasik J., Meynadier J., Blond S., Scherpereel P., Ackerman E., Wiesenstock M., Bonath K., Crammer H. andWünsch E.: Somatostatin, a potent analgesic.Lancet 24, 2 (8413), 1208–1209, 1984.
Chrubasik J.: Intrathecal Somatostatin.Ann. NY Acad. Sci. 531, 133–145, 1988.
Wiesenfield-Hallin Z.: Substance P and somatostatine modulate spinal cords excitability via physiologically different sensory pathway.Brain Res. 372, 172–175, 1986.
Morton C.R., Hutchison W.D., Hendry I.A. andDuggan A.W.: Somatostatin: evidence for a role in thermal nociception.Brain Res. 29, 488 (1–2), 89–96, 1989.
Rezek M., Havlicek V., Leybin L., LaBella F.S. andFriesen H.: Opiate-like naloxone-reversible actions of somatostatin given intracerebrally.Can. J. Physiol. Pharmacol. 56 (2), 227–231, 1978.
Mollenholt P., Post C., Paulsson I. andRawal N.: Intrathecal and epidural somatostatin in rats: can antinociception, motor effects and neurotoxicity be separated?Pain 43 (3), 363–370, 1990.
Mollenholt P., Post C., Paulsson I. andRawal N.: Intrathecal somatostatin in the guinea pig: effects on spinal cord blood flow, histopathology and motor function.Pain 51 (3), 343–347, 1992.
Mollenholt P., Post C., Rawal N., Freedman J., Hokfelt T. andPaulsson I.: Antinociceptive and ‘neurotoxic’ actions of somatostatin in rat spinal cord after intrathecal administration.Pain 32 (1), 95–105, 1988.
Chrubasik J., Meynadier J., Scherpereel P. andWunsch E.: The effect of epidural somatostatin on postoperative pain.Anesth. Analg. 64 (11), 1085–1088, 1985.
Taura P., Planella V., Balust J., Beltran J., Anglada T., Carrero E. andBurgues S.: Epidural somatostatin as an analgesic in upper abdominal surgery: a double-blind study.Pain 59 (1), 135–40, 1994.
Matucci-Cerinic M., Lotti T., Cappugi P., Boddi V., Fattorini L. andPanconesi E.: Somatostatin treatment of psoriatic arthritis.Int. J. Dermatol. 27 (1), 56–58, 1988.
Matucci-Cerinic M., Borrelli F., Generini S., Cantelmo A., Marcucci I., Martelli F., Romagnoli P., Bacci S., Conz A., Marinelli P. et al.: Somatostatin-induced modulation of inflammation in experimental arthritis.Arthritis. Rheum. 38 (11), 1687–1693, 1995.
Mollenholt P., Rawal N., Gordh T. Jr andOlsson Y.: Intrathecal and epidural somatostatin for patients with cancer. Analgesic effects and postmortem neuropathologic investigations of spinal cord and nerve roots.Anesthesiology 81 (3), 534–542, 1994.
Taura P., Planella V., Balust J., Anglada T., Carrero E. andBurgues S.: Use of epidural somatostatin as an analgesic in upper abdominal surgery: a double-blink study: reply.Pain, 388–389, 1995.
Gaumann D.M., Grabow T.S., Yaksh T.L., Casey S.J. andRodriguez M.: Intrathecal somatostatin, somatostatin analogs, substance P analog and dynorphin A cause comparable neurotoxicity in rats.Neuroscience 39 (3), 761–774, 1990.
Chatila R., Ferayorni L., Gupta T. andGroszmann R.J.: Local arterial vasoconstriction induced by octreotide in patients with cirrhosis.Hepatology 31 (3), 572–576, 2000.
Sieber C.C., Mosca P.G. andGroszmann R.J.: Effect of somatostatin on mesenteric vascular resistance in normal and portal hypertensive rats.Am. J. Physiol. 262 (2 Pt 1), G274–7, 1992.
Bergerot A., Reynier-Rebuffel A.M., Callebert J. andAubineau P.: Long-term superior cervical sympathectomy induces mast cell hyperplasia and increases histamine and serotonin content in the rat dura mater.Neuroscience 96, (1), 205–123, 2000.
Kao P.C., Laws E.R. Jr andZimmerman D.: Somatomedin C/insulin-like growth factor I levels after treatment of acromegaly.Ann. Clin. Lab. Sci. 22 (2), 95–99, 1992.
Vance M.L. andHarris A.G.: Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group.Arch. Intern. Med. 151 (8), 1573–1578, 1991.
Ezzat S., Snyder P.J., Young W.F., Boyajy L.D., Newman C., Klibanski A., Molitch M.E., Boyd A.E., Sheeler L., Cook D.M. et al.: Octreotide treatment of acromegaly. A randomized, multicenter study.Ann. Intern. Med. 1, 117 (9), 711–718, 1992.
Toppila J., Niittymaki P., Porkka-Heiskanen T. andStenberg D.: Intracerebroventricular and locus coeruleus microinjections of somatostatin antagonist decrease REM sleep in rats.Pharmacol. Biochem. Behav. 66 (4), 721–727, 2000.
Beranek L., Obal F. Jr,Taishi P., Bodosi B., Laczi F. andKrueger J.M.; Changes in rat sleep after single and repeated injections of the long-acting somatostatin analog octreotide.Am. J. Physiol. 273 (4 Pt 2), R1484–1491, 1997.
Epelbaum J., Dournaud P., Fodor M. andViollet C.: The neurobiology of somatostatin.Crit. Rev. Neurobiol. 8 (1–2), 25–44, 1994 Review.
Matsuno M., Sohmiya M., Yamamoto H. andKato Y.: An acromegalic patient with pulsatile secretion of growth hormone (GH) coincident with the slow-wave sleep.Endocr. J. 45 (5), 687–692, 1998.
Van Cauter E., Plat L. andCopinschi G.: Interrelations between sleep and the somatotropic axis.Sleep. 15, 21(6), 553–566, 1998. Review.
Toppila J., Asikainen M., Alanko L., Turek F.W., Stenberg D. andPorkka-Heiskanen T.: The effect of REM sleep deprivation on somatostatin and growth hormone-releasing hormone gene expression in the rat hypothalamus.J. Sleep. Res. 5(2), 115–122, 1996.
Buyse B., Michiels E., Bouillon R., Bobbaers H. andDemedts M.: Relief of sleep apnoea after treatment of acromegaly: report of three cases and review of the literature.Eur. Respir. J. 10 (6), 1401–1404, 1997.
Grunstein R.R., Ho K.K. andSullivan C.E.: Effect of octreotide, a somatostatin analog, on sleep apnea in patients with acromegaly.Ann. Intern. Med. 121 (7), 478–483, 1994.
Kravetz D., Bosch J., Arderiu M.T., Pizcueta M.P., Casamitjana R., Rivera F. andRodes J.: Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats.Am. J. Physiol. 254 (3 Pt 1), G322–328, 1988.
Musolino N.R., Marino Junior R. andBronstein M.D.: Headache in acromegaly: dramatic improvement with the somatostatin analogue SMS 201-995.Clin. J. Pain. 6 (3), 243–245, 1990.
Edvinsson L. andGoadsby P.J.: Neuropeptides in migraine and cluster headache.Cephalalgia 14 (5), 320–327, 1994.
Coderre T.J., Basbaum A.I. andLevine J.D.: Neural control of vascular permeability: interactions between primary afferents, mast cells, and sympathetic efferents.J. Neurophysiol. 62 (1), 48–58, 1989.
Gardi J., Obal F. Jr,Fang J., Zhang J. andKrueger J.M.: Diurnal variations and sleep deprivation-induced changes in rat hypothalamic GHRH and somatostatin contents.Am. J. Physiol. 277 (5 Pt 2): R1339–1344, 1999.
Jackson Robert II L., Lowell B.A. andJohn A.: Oates,Disorders of vasodilator hormones: carcinoïd syndrome and mastocytosis. In: Williams textbook of endocrinology. 9th edition. Ed. W.B. Saunders company, 1711–1732, 1998.
Kudrow L. andKudrow D.B.: Association of sustained oxyhemoglobin desaturation and onset of cluster headache attacks.Headache 30 (8), 474–480, 1990.
Kudrow L.: Response of cluster headache attacks to oxygen inhalation.Headache 21 (1), 1–4, 1981. PMID: 7007285.
Shen J.M., Schaaning J., White L., Kruszewski P., Bjaanes E. andSjaastad O.: Cluster headache: the ventilatory response to transient hypoxia with pure nitrogen.Headache 33 (9), 476–482, 1993. PMID: 8262793
Kudrow L. andKudrow D.B.: The role of chemoreceptor activity and oxyhemoglobin desaturation in cluster headache.Headache 33 (9), 483–484, 1993.
Descamps V., Duval X., Crickx B., Bouscarat F., Coffin B. andBelaich S.: Global improvement of systemic scleroderma under long-term administration of octreotide.Eur. J. Dermatol. 9 (6), 446–448, 1999.
O’Byrne K.J., Schally A.V., Thomas A., Carney D.N. andSteward W.P.: Somatostatin its receptors and analogs, in lung cancer.Chemotherapy.47 (Suppl. 2), 78–108, 2001.
Van Hagen P.M., Krenning E.P., Kwekkeboom D.J., Reubi J.C., Anker-Lugtenburg P.J., Lowenberg B. andLamberts S.W.: Somatostatin and the immune and haematopoetic system; a review.Eur. J. Clin. Invest. 24 (2), 91–99, 1994.
Lambrecht B.N.: Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation.Respir Res. 2 (3), 133–138, 2001.
Caleri D., Marabini S., Panconesi A. andPietrini U.: A pharmacological approach to the analgesizing mechanism of somatostatin in cluster headache.Ric. Clin. Lab. 17 (2), 155–162, 1987.
Pascual J., Freijanes J., Berciano J. andPesquera C.: Analgesic effect of octreotide in headache associated with acromegaly is not mediated by opioid mechanisms.Case report. Pain. 47 (3), 341–344, 1991.
Solomon S.: Cluster headache and the nervus intermedius.Headache 26 (1), 3–8, 1986.
Lefevre J.P., Simmat G., Bataille B., Salles M., Gil R., Boissonnot L. andRoualdes G.: Cluster headache due to meningioma. 2 cases.Presse Med. 13 (38), 2323, 1984.
Canepari C. andRiva M.: Apropos of a case of cluster headache and a space-occupying lesion in the brain.Minerva Med. 76 (26–27), 1285–1287, 1985.
Appelbaum J. andNoronha A.: Pericarotid cluster headache.J. Neurol. 236 (7), 430–431, 1989.
Hannerz J.: A case of parasellar meningioma mimicking cluster headache.Cephalalgia 9 (4), 265–269, 1989.
Rowed D.W.: Chronic cluster headache managed by nervus intermedius section.Headache 30 (7), 401–406, 1990.
Hindfelt B. andOlivecrona H.: Cerebral arteriovenous malformation and cluster-like headache.Headache 31 (8), 514–517, 1991.
West P. andTodman D.: Chronic cluster headache associated with a vertebral artery aneurysm.Headache 31 (4), 210–2102, 1991.
Koenigsberg A.D., Solomon G.D. andKosmorsky G.: Psuedoaneurysm within the cavernous sinus presenting as cluster headache.Headache 34 (2), 111–113, 1994.
Munoz C., Diez-Tejedor E., Frank A. andBarreiro P.: Cluster headache syndrome associated with middle cerebral artery arteriovenous malformation.Cephalalgia 16 (3), 202–205, 1996.
Nagtegaal J.E., Smits M.G., Swart A.C., Kerkhof G.A. andvan der Meer Y.G.: Melatonin responsive headache in delayed sleep phase syndrome: preliminary observations.Headache 38 (4), 303–307, 1998.
Sherpherd Gordon M.:Biorhythm in Neurobiology, 3rd edition New York 1994, Oxford University Press; pp. 539–561.
Costa A., Leston J.A., Cavallini A. andNappi G.: Cluster headache and periodic affective illness: common chronobiological features.Funct. Neurol. 13 (3), 263–272, 1998.
Waldenlind E., Ekbom K., Wetterberg L., Fanciullacci M., Marabini S., Sicuteri F., Polleri A., Murialdo G. andFilippi U.: Lowered circannual urinary melatonin concentrations in episodic cluster headache.Cephalalgia 14 (3), 199–204, 1994.
Leone M. andBussone G.: A review of hormonal findings in cluster headache. Evidence for hypothalamic involvement.Cephalalgia 13 (5), 309–317, 1993.
Chazot G., Claustrat B., Brun J. andZaidan R.: Effects on the patterns of melatonin and cortisol in cluster headache of a single administration of lithium at 7.00 p.m. daily over one week: a preliminary report.Pharmacopsychiatry 20 (5), 222–223, 1987.
Dodick D.W. andCapobianco D.J.: Treatment and management of cluster headache.Curr. Pain Headache Rep. 5 (1), 83–91, 2001.
Ekbom K. andHardebo J.E.:Drug treatment of cluster headache.In: Diener HC. ed. Drug Treatment of Migraine and Other Headaches. Basel: Karger, 322–328, 2000.
The Sumatriptan Cluster Headache Study Group: Treatment of acute cluster headache with sumariptan.N. Engl. J. Med. 325, 322–326, 1991.
Diener H.C.: Sumatriptan in the treatment of cluster headache.Cephalalgia 21 (Suppl. 1), 16–17, 2001.
Andersson P.G. andJespersen L.T.: Dihydroergotamine nasal spray in the treatment of attacks of cluster headache. A double-blind trial versus placebo.Cephalalgia 6 (1), 51–54, 1986.
Boiardi A., Gemma M., Porta E., Peccarisi C. andBussone G.: Calcium entry blocker: treatment in acute pain in cluster headache patients.Ital. J. Neurol. Sci. 7 (5) 531–534, 1986.
Damasio H.: Drug management of adult vascular headaches (migraine and cluster headache): Part II — Prevention and attacks.Iowa Med. 74 (12), 536, 538–539, 1984.
Wiest R., Tsai M.H. andGroszmann R.J.: Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats.Gastroenterology 120 (4), 975–983, 2001.
Sicuteri F., Renzi D. andGeppetti P.: Substance P and enkephalins: a creditable tandem in the pathophysiology of cluster headache and migraine.Adv. Exp. Med. Biol. 198 Pt B, 145–152, 1986.
Sicuteri F., Panconesi A., Del Bianco P.L., Franchi G. andAnselmi B.: Venospastic activity of somatostatin in vivo in man: naloxone reversible tachyphylaxis.Int. J. Clin. Pharmacol. Res. 4 (3), 253–257, 1984.
Sicuteri F., Geppetti P., Marabini S. andLembeck F.: Pain relief by somatostatin in attacks of cluster headache.Pain 18 (4), 359–65, 1984.
Otsuka F., Kageyama J., Ogura T. andMakino H.: Cluster headache dependent upon octreotide injection.Headache 38 (8), 629, 1998.
Paunovic V.R. andPopovic V.: The development of dependence to an octapeptide somatostatin analog: contribution to the study of somatostatin analgesia.Biol. Psychiatry 26 (1), 97–101, 1989.
Meynadier J., Chrubasik J., Dubar M. andWunsch E.: A report of two cases. Intrathecal somatostatin in terminally ill patients. A report of two cases.Pain.23 (1), 9–12, 1985.
Schmidt K., Althoff P.H., Harris A.G., Prestele H., Schumm-Draeger P.M. andUsadel K.H.: Analgesic effect of the somatostatin analogue octreotide in two acromegalic patients: a double-blind study with long-term follow-up.Pain 53 (2), 223–227, 1993.
Author information
Authors and Affiliations
About this article
Cite this article
Cheynet, M., Peyron, R., Navez, M.L. et al. Algies vasculaires de la face associées à une acromégalie et soulagées par la somatostatine. Doul. et Analg. 15, 163–168 (2002). https://doi.org/10.1007/BF03008080
Issue Date:
DOI: https://doi.org/10.1007/BF03008080